Get 20% lifetime commission for referring investors to digrin.com
here.
Vor Biopharma Inc. (VOR) Financials
VOR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 481.1 million | 681.3 million |
| March 31, 2026 | 506.7 million | 657.2 million |
| Dec. 31, 2025 | 464.1 million | 628.4 million |
| Sept. 30, 2025 | 176.2 million | 2.4 billion |
VOR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -25.8 million | 9.4 million |
| March 31, 2026 | -38.3 million | 8.9 million |
| Dec. 31, 2025 | -23.1 million | 9.0 million |
| Sept. 30, 2025 | -53.9 million | 8.0 million |
VOR Net Income
No data available :(
VOR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 466.1 million | - | 2.9 million |
| March 31, 2026 | 491.5 million | 2.6 million | 307000 |
| Dec. 31, 2025 | 455.2 million | - | 2.7 million |
| Sept. 30, 2025 | 170.5 million | - | 2.8 million |
VOR Shares Outstanding
VOR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 120000 | 25.9 million | 21.9 million | - |
| March 31, 2026 | 48000 | 17.6 million | 17.5 million | - |
| Dec. 31, 2025 | 314000 | 19.2 million | 16.8 million | - |
| Sept. 30, 2025 | 244000 | 14.1 million | 14.4 million | - |
VOR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 28000 |
| Dec. 31, 2025 | - | 23000 |
| Sept. 30, 2025 | - | - |
VOR
Price: $23.01
52 week price:
Earnings Per Share: 171.01 USD
P/E Ratio: 0.13
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 63919
Market Capitalization: 1.2 billion